Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 1 feed behind: Insider filings, 1 day · Every feed →

All 10Congress 0Executive branch 0Insiders 10
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

BCAX · Insiders · $50K+ · 10 trades

Trades
10
Buys 0 · Sells 10
People
3
Stocks
1
Disclosed value
$3.4M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLRyan Cohlhepp President, COO & Interim CEOBCAX Bicara Therapeutics Inc.$320Kdisclosed Sep 10 · filed 2 days after the trade
  2. ▼ SELLRyan Cohlhepp President, COO & Interim CEOBCAX Bicara Therapeutics Inc.$80.7Kdisclosed Sep 10 · filed 2 days after the trade
  3. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$525Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLClaire Mazumdar Chief Executive OfficerBCAX Bicara Therapeutics Inc.$280Kdisclosed Aug 12 · filed 2 days after the trade
  5. ▼ SELLIvan Hyep Chief Financial OfficerBCAX Bicara Therapeutics Inc.$350Kdisclosed Aug 12 · filed 2 days after the trade
  6. ▼ SELLClaire Mazumdar Chief Executive OfficerBCAX Bicara Therapeutics Inc.$283Kdisclosed Jul 14 · filed 4 days after the trade
  7. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$128Kdisclosed Jul 10 · filed 2 days after the trade
  8. ▼ SELLIvan Hyep Chief Financial OfficerBCAX Bicara Therapeutics Inc.$132Kdisclosed Jul 10 · filed 2 days after the trade
  9. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$657Kdisclosed Jul 10 · filed 2 days after the trade
  10. ▼ SELLIvan Hyep Chief Financial OfficerBCAX Bicara Therapeutics Inc.$651Kdisclosed Jul 10 · filed 2 days after the trade